Loading...

Shield Therapeutics plc

SHIEF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.11
$-0.05(-32.70%)
U.S. Market opens in 7h 33m

Shield Therapeutics plc (SHIEF) Stock Overview

Explore Shield Therapeutics plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap120.7M
P/E Ratio-7.95
EPS (TTM)$-0.02
ROE1.01%
Fundamental Analysis

AI Price Forecasts

1 Month$0.15
3 Months$0.16
1 Year Target$0.19

SHIEF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Shield Therapeutics plc (SHIEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 28.69, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.95 and a market capitalization of 120.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-32.70%
5-Day Change
-32.70%
1-Month Change
-10.32%
3-Month Change
-25.24%
6-Month Change
14.95%
Year-to-Date (YTD) Change
-22.60%
1-Year Change
232.35%
3-Year Change
15.31%
5-Year Change
-80.18%
All-Time (Max) Change
-95.39%

Contact Information

https://www.shieldtherapeutics.com
44 1915 118 500
Northern Design Centre, Gateshead, NaN, NE8 3DF

Company Facts

63 Employees
IPO DateDec 6, 2019
CountryGB
Actively Trading

Frequently Asked Questions